Cannabis in Netherlands
Mixed / PartialOverview
The Netherlands occupies a unique position in global cannabis policy through its long-standing "gedoogbeleid" (tolerance policy) dating back to 1976. Under this policy, the sale of small amounts of cannabis (up to 5 grams) in licensed coffee shops is tolerated by authorities, though cannabis technically remains illegal under Dutch law. This creates the famous paradox where front-door sales to consumers are tolerated while the back-door supply to coffee shops operates in a legal gray area.
There are approximately 570 licensed coffee shops operating across the Netherlands, down from a peak of over 1,500 in the 1990s. Amsterdam alone accounts for roughly 170 coffee shops, making it a global symbol of cannabis tolerance. Coffee shops must adhere to strict rules: no advertising, no hard drugs, no sales to minors under 18, no public nuisance, and maximum 500-gram inventory.
In an effort to address the illegal supply chain, the Dutch government launched a pilot program (the Wietexperiment) in 2023 in select municipalities to test a regulated supply chain for coffee shops. Under this program, licensed growers supply cannabis directly to participating coffee shops, creating a fully legal seed-to-sale chain for the first time. The pilot is expected to run for four years before a decision on national implementation.
Medical cannabis has been available in the Netherlands since 2003 through the Office of Medicinal Cannabis (Bureau voor Medicinale Cannabis), a government agency under the Ministry of Health that oversees the production and distribution of pharmaceutical-grade cannabis. Dutch medical cannabis is grown by a single licensed producer (Bedrocan) and is available through pharmacies with a prescription.
Key Facts
- Tolerance policy for coffee shop cannabis sales since 1976
- Approximately 570 licensed coffee shops, 170 in Amsterdam
- Cannabis technically remains illegal — sales are tolerated, not legalized
- Regulated supply chain pilot (Wietexperiment) launched in 2023
- Medical cannabis available since 2003 through pharmacies
- Bedrocan is the sole licensed medical cannabis producer
- Maximum purchase of 5 grams per transaction at coffee shops
Recent Developments
Regulated supply chain pilot expanding to additional municipalities
Government evaluating results for potential nationwide implementation
Coffee shop tourism policies under ongoing review
Medical cannabis production capacity being assessed for expansion
Investment Implications
The Netherlands' established but informal cannabis market offers limited direct investment opportunities due to the quasi-legal nature of the coffee shop system. However, the regulated supply chain pilot could create a formal commercial market if adopted nationally. Bedrocan's model of pharmaceutical-grade production is influential globally. Investors should watch the pilot program outcomes — success could lead to a fully regulated Dutch cannabis market and create opportunities for licensed producers and retailers.